$AMAT

Applied Materials Cratered in The last 3 Months: One Wall Street Sell Side Firm Predicts it Will Nearly Double Within 12 Months

Applied Materials (AMAT) shares fell 22% over three months, despite strong earnings and rising analyst estimates. The company reported $9.115B revenue, up 24.8% YoY, and beat EPS estimates. Analysts predict 36.9% upside to $635.33. The decline followed an investor day where no spending forecast was provided, raising uncertainty. Peers Lam Research (LRCX) and KLA (KLAC) also fell but less sharply. AMAT's 52-week high is $738.88, and it trades at 23x forward earnings.

Original reporting
Published Oct 14, 2026, 11:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 11:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Applied Materials Cratered in The last 3 Months: One Wall Street Sell Side Firm Predicts it Will Nearly Double Within 12 Months — source image
Decision brief

The 30-second read

$AMATBearishLow
01

Why it matters

The lack of a spending forecast fuels uncertainty, keeping the stock depressed despite strong earnings and rising estimates.

02

Market read

Provides a recap of existing data; limited new trading insight.

03

What to watch

Potential upside from AI‑driven demand and strong DRAM packaging growth may be under‑appreciated.

Relevance 4/10Novelty 2/10Timing: none

Background

The piece reviews Applied Materials' recent price decline, earnings beat, and forward guidance, noting the absence of an investor‑day spending outlook.

Company-level read

Ticker impact

$AMATBearishMedium confidence
Context

Applied Materials shares have dropped 22% over three months to $464.24, with guidance uncertainty after investor‑day omission.

Expected impact

likely continued downside as market prices in uncertainty over 2027 outlook.

Evidence & confidence

The article highlights a recent multi‑month slide and no new catalyst, suggesting further weakness until guidance clarity.

Market effects

Semiconductor equipment sector shows broad weakness, but Applied Materials is the most impacted.

U.S. tech stocks may face modest pressure.

Limited; primarily affects investors in semiconductor equipment equities.

Counterpoint

If clean‑room capacity improves faster than expected, the stock could rebound sharply.

Key entities

  • Applied Materials

    Semiconductor equipment maker (NASDAQ: AMAT).

Related articles

$BACMed

US Futures Hold Steady Ahead of Inflation Report

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

$AMATMed

Applied Materials Targets AI-Led Market Share Gains and Higher Margins by 2030

Applied Materials (AMAT) expects to gain market share in wafer-fab equipment, leading-edge logic, DRAM, and advanced packaging by 2030. The company anticipates revenue growth in process control and services, with AIx platform improving yield and factory output. Financial targets include $12B+ in services revenue and 54% gross margin by 2030. AMAT plans to return 80-100% of free cash flow to shareholders.

$AMATHighAI 8/10

Why Applied Materials Sank Today

Applied Materials (AMAT) shares fell 7.2% after an investor presentation lacked revenue growth projections. The company forecast 2030 margins of 54% gross and 40% operating, with services revenue exceeding $12B. Investors reacted negatively to the absence of overall revenue guidance, despite bullish long-term outlooks on AI-driven growth.

$JPMHighAI 8/10

Wall Street Lunch: Bank Earnings Nothing To Write Home About (undefined:JPM)

JPMorgan Chase (JPM) missed Q3 earnings estimates, with Fixed Income & Markets revenue falling 4% Y/Y. Goldman Sachs (GS) beat estimates, while Wells Fargo (WFC) and Citigroup (C) showed mixed results. UnitedHealth Group (UNH) raised its full-year outlook, and Johnson & Johnson (JNJ) reported a Q3 beat but saw shares weighed down by MedTech revenue. Applied Materials (AMAT) declined post-investor presentation. Fund managers increased tech sector exposure to a six-year high.